Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

TRANSPLANTATION

Use of hepatitis C viraemic organs in kidney transplantation: a need to hit the pause button?

Nature Reviews Gastroenterology & Hepatology volume 16, pages 5–6 (2019)Cite this article

Subjects

Innovative solutions are needed to overcome the global disparity in patients awaiting kidney transplantation versus donor organs available. A new study reports a promising new strategy of transplanting kidneys from HCV-infected donors into HCV-uninfected recipients and treating their HCV with direct-acting antivirals post-transplant — recipients achieved HCV cure with excellent one-year kidney allograft function.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Hart, A. et al. OPTN/SRTR 2016 annual data report: kidney. Am. J. Transplant. 18, S18–S113 (2018).

    Article  Google Scholar 

  2. Wu, D. A. et al. Global trends and challenges in deceased donor kidney allocation. Kidney Int. 91, 1287–1299 (2017).

    Article  Google Scholar 

  3. Mohan, S. et al. Factors leading to the discard of deceased donor kidneys in the United States. Kidney Int. 94, 187–198 (2018).

    Article  Google Scholar 

  4. Levitsky, J. et al. The American Society of Transplantation Consensus Conference on the use of hepatitis C viremic donors in solid organ transplantation. Am. J. Transplant. 17, 2790–2802 (2017).

    Article  CAS  Google Scholar 

  5. Morales, J. M. & Fabrizi, F. Hepatitis C and its impact on renal transplantation. Nat. Rev. Nephrol. 11, 172–182 (2015).

    Article  CAS  Google Scholar 

  6. Saxena, V. et al. Safety and efficacy of current direct-acting antiviral regimens in kidney and liver transplant recipients with hepatitis C: results from the HCV-TARGET study. Hepatology 66, 1090–1101 (2017).

    Article  CAS  Google Scholar 

  7. Chan, C. et al. Immune-mediated graft dysfunction in liver transplant recipients with hepatitis C virus treated with direct-acting antiviral therapy. Am. J. Transplant. 18, 2506–2512 (2018).

    Article  CAS  Google Scholar 

  8. Goldberg, D. S., Abt, P. L. & Reese, P. P. Transplanting HCV-infected kidneys into uninfected recipients. N. Engl. J. Med. 377, 1105 (2017).

    PubMed  Google Scholar 

  9. Reese, P. P. et al. Twelve-month outcomes after transplant of hepatitis C-infected kidneys into uninfected recipients: a single-group trial. Ann. Intern. Med. 169, 273–281 (2018).

    Article  Google Scholar 

  10. Durand, C. M. et al. Direct-acting antiviral prophylaxis in kidney transplantation from hepatitis C virus-infected donors to noninfected recipients: an open-label nonrandomized trial. Ann. Intern. Med. 168, 533–540 (2018).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Gastroenterology/Hepatology, University of California San Francisco, San Francisco, CA, USA

    Allison J. Kwong & Norah A. Terrault

Authors
  1. Allison J. Kwong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Norah A. Terrault
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Norah A. Terrault.

Ethics declarations

Competing interests

N.A.T. has received institutional grant support from AbbVie, Allergan, BMS, Gilead and Merck. A.J.K. reports no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kwong, A.J., Terrault, N.A. Use of hepatitis C viraemic organs in kidney transplantation: a need to hit the pause button?. Nat Rev Gastroenterol Hepatol 16, 5–6 (2019). https://doi.org/10.1038/s41575-018-0071-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41575-018-0071-0

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing